Maxzide-25 Interactions
There are 513 drugs known to interact with Maxzide-25 (hydrochlorothiazide/triamterene), along with 20 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 54 are major, 421 are moderate, and 38 are minor.
- View all 513 medications that may interact with Maxzide-25
- View Maxzide-25 alcohol/food interactions (2)
- View Maxzide-25 disease interactions (20)
Most frequently checked interactions
View interaction reports for Maxzide-25 (hydrochlorothiazide / triamterene) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atenolol
- atorvastatin
- Celebrex (celecoxib)
- CoQ10 (ubiquinone)
- cyclobenzaprine
- Cymbalta (duloxetine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- levothyroxine
- Lipitor (atorvastatin)
- lisinopril
- losartan
- metformin
- metoprolol
- Norvasc (amlodipine)
- omeprazole
- potassium chloride
- prednisone
- simvastatin
- Singulair (montelukast)
- Synthroid (levothyroxine)
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zoloft (sertraline)
Maxzide-25 alcohol/food interactions
There are 2 alcohol/food interactions with Maxzide-25 (hydrochlorothiazide / triamterene).
Maxzide-25 disease interactions
There are 20 disease interactions with Maxzide-25 (hydrochlorothiazide / triamterene) which include:
- acidosis
- diabetes
- electrolytes/fluid
- hyperkalemia
- liver disease
- renal dysfunction
- anuria
- electrolyte losses
- liver disease
- lupus erythematosus
- renal function disorders
- nephrolithiasis
- hyperuricemia
- asthma
- diabetes
- hyperlipidemia
- hyperparathyroidism
- hyperuricemia
- thyroid function tests
- folate antagonism
More about Maxzide-25 (hydrochlorothiazide / triamterene)
- Maxzide-25 consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: potassium sparing diuretics with thiazides
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.